HRT FINANCIAL LP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$302
-99.9%
50,326
-74.1%
0.00%
-33.3%
Q1 2021$565,000
+32.6%
194,242
+46.5%
0.01%
-33.3%
Q4 2020$426,000
+1836.4%
132,559
+572.5%
0.01%
+800.0%
Q2 2020$22,000–19,710–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders